William D. Waddill's Net Worth
$3.88 Million
Who is William D. Waddill?
William D. Waddill has an estimated net worth of $3.88 Million. This is based on reported shares across multiple companies, which include Protagonist Therapeutics, Inc, ARROWHEAD PHARMACEUTICALS, INC., Calithera Biosciences, Inc., Annexon, Inc., OncoMed Pharmaceuticals Inc, and Turnstone Biologics Corp..
SEC CIK
William D. Waddill's CIK is 0001553338
Past Insider Trading and Trends
2024 was William D. Waddill's most active year for acquiring shares with 7 total transactions. William D. Waddill's most active month to acquire stocks was the month of December. 2024 was William D. Waddill's most active year for disposing of shares, totalling 8 transactions. William D. Waddill's most active month to dispose stocks was the month of December. 2023 saw William D. Waddill paying a total of $380,819.67 for 81,447 shares, this is the most they've acquired in one year. In 2020 William D. Waddill cashed out on 29,000 shares for a total of $1,163,820.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $41.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$28.94 | -$256,960.00 | 12K |
Scheduled
|
Sep 10
| ||
Form 4
|
—
|
0
|
$26.44 | -$216,960.00 | 12K |
Scheduled
|
Jul 24
| ||
Form 4
|
—
|
0
|
$23.94 | -$176,960.00 | 12K |
Scheduled
|
Jun 7
| ||
Form 4
|
—
|
0
|
$18.72 | -$327,618.75 | 12K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
∞
| 12K |
$8.59 | $103,080.00 | 12K |
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Snapshot price: $22.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.59% | -3.93K |
$38.07 | -$149,758.54 | 47.87K |
Scheduled
|
Jan 11
| ||
Form 4
| +40.71% | 14.99K |
$25.41 | $380,819.67 | 51.8K |
Dec 15
| |||
Form 4
| +14.52% | 4.67K |
$30.00 | -$96,000.00 | 36.82K |
Scheduled
|
Jan 9 - Jan 10
| ||
Form 4
| +24.85% | 6.4K |
—
|
—
| 32.15K |
Jan 7
| |||
Form 4
| -14.88% | -4.50K |
$64.72 | -$291,244.28 | 25.75K |
Scheduled
|
Jan 3
| ||
Form 4
| +21.00% | 5.25K |
$76.08 | -$285,300.00 | 30.25K |
Jan 1 - Jan 4
| |||
Form 4
| -10.71% | -3.00K |
$71.26 | -$213,780.00 | 25K |
Dec 10
| |||
Form 4
| -48.15% | -26.00K |
$36.54 | -$950,040.00 | 28K |
May 11
| |||
Form 4
| +16.13% | 7.5K |
—
|
—
| 54K |
Jan 1
| |||
Form 4
| -15.45% | -8.50K |
$14.77 | -$125,545.00 | 46.5K |
Jan 11
| |||
Form 4
| +120.00% | 30K |
—
|
—
| 55K |
Jan 1
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03
SR. VP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 4
| -50.00% | -17.48K |
—
|
—
| 17.48K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
| +525.00% | 13.13K |
$2.64 | $34,650.00 | 15.63K |
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +72.50% | 6.8K |
$3.43 | $23,283.84 | 16.17K |
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Annexon, Inc. (ANNX) Snapshot price: $5.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OncoMed Pharmaceuticals Inc No price found
SVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||